(AOF) – Lumibird reacted to information from La Lettre according to which the laser specialist is in discussions to resell its 37% in Cilas to the tandem of shareholders Safran and MBDA. On the stock market, Lumibird shares fell 0.76% to 13 euros. In a press release, the company indicated that it was “directing its discussions on the Cilas file towards a partnership that is more technological and industrial than capitalistic”.
The laser technology specialist added that “its investment plan in Cilas does not extend beyond a stake of 37% of the capital, without significant influence”.
Lumibird acquired this stake in 2021 from Areva for 7.5 million euros.
“In 2022, ArianeGroup resold its shares in Cilas to the Safran and MBDA duo which today holds 63% of the capital. The amount of the transaction would be between 50 million euros and 100 million euros, thus valuing Cilas in 2022 at 80/160 million euros,” explains Invest Securities. The analyst deduces that the sale of Lumibird’s shares could bring him between 30 and 60 million euros.
The interest in a rapprochement remains undiminished, and has even strengthened this year. In this context, the group’s desire is to build an agreement with Cilas, where Lumibird will contribute very actively to the development of a sovereign defense sector,” the company concluded.
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
